We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Fully-Automated Chemiluminescence Analyzer Enables Fast, Convenient Testing in Clinical and Emergency Settings

By LabMedica International staff writers
Posted on 15 May 2023
Print article
Image: The MCL60 fully-automated chemiluminescence analyzer (Photo courtesy of RealMind)
Image: The MCL60 fully-automated chemiluminescence analyzer (Photo courtesy of RealMind)

In recent times, there has been a surge in the need for fast and convenient testing in clinical and emergency scenarios. Furthermore, the constant rise in the standards for test performance and result accuracy is driving advancements in in-vitro diagnostic (IVD) test platforms. Now, a strategic partnership has now further expanded the range of diagnostic solutions available for laboratories in China by offering a fully automated chemiluminescence immunoassay (CLIA) analyzer along with compatible assay kits to serve the region's patient community.

Roche Diagnostics China (Basel, Switzerland) is the exclusive agent in mainland China of RealMind Biotech’s (Nanjing, China) MCL60 CLIA analyzer, along with its matching chemiluminescence assay kits (including cardiac biomarkers, inflammatory biomarkers, sexual hormones, thyroid function, stomach function, etc.). The MCL60 bench-top CLIA system employs direct CLIA with acridinium ester (AE) label and is compatible with various sample types, such as capillary blood, whole blood, serum, and plasma. The MCL60 is fully automated with a throughput of up to 144 tests/hour, and the first result is available in 13 minutes. It fulfills the clinical requirements for flexible, convenient, precise, and efficient testing, and is applicable in a wide range of departments including pediatrics, obstetrics, emergency, and ICUs.

Traditional automatic chemiluminescence analyzers are typically larger in size, come with numerous accessories, and are costly, hence they are typically situated only in central or emergency laboratories. The MCL60 integrates the benefits of CLIA technology into a more compact platform, achieving high-accuracy, high-throughput, and miniaturized automatic CLIA testing. It requires minimal lab space and can execute over 70 highly sensitive assays including cardiac, inflammatory, children growth hormones, gastric function, cytokines, glycometabolism, preeclampsia, etc.

Related Links:
RealMind Biotech 
Roche Diagnostics China 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.